-
1
-
-
0034700438
-
Prognosis of cancers associated with venous thromboembolism
-
Sorensen HT, Mellemkjaer L, Olsen JH, et al. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000;343:1846-1850.
-
(2000)
N Engl J Med
, vol.343
, pp. 1846-1850
-
-
Sorensen, H.T.1
Mellemkjaer, L.2
Olsen, J.H.3
-
2
-
-
13244251018
-
Thrombosis and cancer: Implications beyond Trousseau
-
Kakkar AK, Levine MN. Thrombosis and cancer: implications beyond Trousseau. J Thromb Haemost. 2004;2:1-2.
-
(2004)
J Thromb Haemost
, vol.2
, pp. 1-2
-
-
Kakkar, A.K.1
Levine, M.N.2
-
3
-
-
0026762705
-
Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin
-
Green D, Hull RD, Brant R, et al. Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin. Lancet. 1992; 339:1476.
-
(1992)
Lancet
, vol.339
, pp. 1476
-
-
Green, D.1
Hull, R.D.2
Brant, R.3
-
4
-
-
0029925784
-
Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysis
-
Siragusa S, Cosmi B, Piovella F, et al. Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. Am J Med. 1996;100:269-277.
-
(1996)
Am J Med
, vol.100
, pp. 269-277
-
-
Siragusa, S.1
Cosmi, B.2
Piovella, F.3
-
5
-
-
0032699382
-
Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread
-
Hettiarachchi R, Smorenburg S, Ginsberg J, et al. Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread. Thromb Haemost. 1999;82:947-952.
-
(1999)
Thromb Haemost
, vol.82
, pp. 947-952
-
-
Hettiarachchi, R.1
Smorenburg, S.2
Ginsberg, J.3
-
6
-
-
0032955744
-
Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep vein thrombosis: A meta-analysis of randomized, controlled trials
-
Gould MK, Dembitzer AD, Doyle RL, et al. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep vein thrombosis: a meta-analysis of randomized, controlled trials. Ann Intern Med. 1999;130:800-809.
-
(1999)
Ann Intern Med
, vol.130
, pp. 800-809
-
-
Gould, M.K.1
Dembitzer, A.D.2
Doyle, R.L.3
-
7
-
-
3042704507
-
Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS)
-
Kakkar AK, Levine MN, Kadziola Z, et al. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the Fragmin Advanced Malignancy Outcome Study (FAMOUS). J Clin Oncol. 2004;22:1944-1948.
-
(2004)
J Clin Oncol
, vol.22
, pp. 1944-1948
-
-
Kakkar, A.K.1
Levine, M.N.2
Kadziola, Z.3
-
8
-
-
0037775584
-
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
-
Lee AYY, Levine MN, Baker RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003;349:146-153.
-
(2003)
N Engl J Med
, vol.349
, pp. 146-153
-
-
Lee, A.Y.Y.1
Levine, M.N.2
Baker, R.I.3
-
9
-
-
17144385138
-
Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism
-
Lee AYY, Rickles FR, Julian JA, et al. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. J Clin Oncol. 2005;23:2123-2129.
-
(2005)
J Clin Oncol
, vol.23
, pp. 2123-2129
-
-
Lee, A.Y.Y.1
Rickles, F.R.2
Julian, J.A.3
-
10
-
-
12844289104
-
A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer
-
Altinbas M, Coskun HS, Er O, et al. A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer. J Thromb Haemost. 2004;2:1-6.
-
(2004)
J Thromb Haemost
, vol.2
, pp. 1-6
-
-
Altinbas, M.1
Coskun, H.S.2
Er, O.3
-
11
-
-
20244376337
-
The effect of low molecular weight heparin on survival in patients with advanced malignancy
-
Klerk CPW, Smorenburg SM, Otten HM, et al. The effect of low molecular weight heparin on survival in patients with advanced malignancy. J Clin Oncol. 2005;23:2130-2135.
-
(2005)
J Clin Oncol
, vol.23
, pp. 2130-2135
-
-
Klerk, C.P.W.1
Smorenburg, S.M.2
Otten, H.M.3
-
12
-
-
0037775639
-
Cancer-associated thrombosis
-
Bick RL. Cancer-associated thrombosis. N Engl J Med. 2003;349:109-111.
-
(2003)
N Engl J Med
, vol.349
, pp. 109-111
-
-
Bick, R.L.1
-
14
-
-
0031927754
-
Thrombin receptor overexpression in malignant and physiological invasion processes
-
Even-Ram S, Uziely B, Cohen P, et al. Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med 1998;4:909-914.
-
(1998)
Nat Med
, vol.4
, pp. 909-914
-
-
Even-Ram, S.1
Uziely, B.2
Cohen, P.3
-
15
-
-
0029097464
-
Tissue factor expression correlates with histological grade in human pancreatic carcinoma
-
Kakkar AK, Lemoine NR, Scully MF, et al. Tissue factor expression correlates with histological grade in human pancreatic carcinoma. Br J Surg. 1995;82:1101-1104.
-
(1995)
Br J Surg
, vol.82
, pp. 1101-1104
-
-
Kakkar, A.K.1
Lemoine, N.R.2
Scully, M.F.3
-
16
-
-
0032498848
-
A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280
-
Ott I, Fischer EG, Miyagi Y, et al. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol. 1998;140:1241-1253.
-
(1998)
J Cell Biol
, vol.140
, pp. 1241-1253
-
-
Ott, I.1
Fischer, E.G.2
Miyagi, Y.3
-
17
-
-
0024593040
-
Control of angiogenesis with synthetic heparin substitutes
-
Folkman J, Weisz PB, Joullie MM, et al. Control of angiogenesis with synthetic heparin substitutes. Science. 1989;243:1490-1493.
-
(1989)
Science
, vol.243
, pp. 1490-1493
-
-
Folkman, J.1
Weisz, P.B.2
Joullie, M.M.3
-
18
-
-
0033057962
-
Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
-
Vlodavsky I, Friedmann Y, Elkin M, et al. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med. 1999;5:793-802.
-
(1999)
Nat Med
, vol.5
, pp. 793-802
-
-
Vlodavsky, I.1
Friedmann, Y.2
Elkin, M.3
-
19
-
-
25144517952
-
The low molecular weight heparin dalteparin sodium inhibits angiogenesis and induces apoptosis in an experimental tumour model
-
Abstract
-
Nasir FA, Patel HK, Scully MF, et al. The low molecular weight heparin dalteparin sodium inhibits angiogenesis and induces apoptosis in an experimental tumour model. Blood. 2003;102(11). Abstract.
-
(2003)
Blood
, vol.102
, Issue.11
-
-
Nasir, F.A.1
Patel, H.K.2
Scully, M.F.3
-
20
-
-
0035853111
-
Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis
-
Borsig L, Wong R, Feramisco J, et al. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci U S A. 2001;98:3352-3357.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 3352-3357
-
-
Borsig, L.1
Wong, R.2
Feramisco, J.3
-
21
-
-
13244275111
-
Increased incidence of neoplasia of the digestive tract in men with persistent activation of the coagulant pathway
-
Miller GJ, Bauer KA, Howarth DJ, et al. Increased incidence of neoplasia of the digestive tract in men with persistent activation of the coagulant pathway. J Thromb Haemost. 2004;2:2107-2114.
-
(2004)
J Thromb Haemost
, vol.2
, pp. 2107-2114
-
-
Miller, G.J.1
Bauer, K.A.2
Howarth, D.J.3
-
22
-
-
0034729786
-
Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism: Duration of Anticoagulation Trial
-
Schulman S, Lindmarker P. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism: Duration of Anticoagulation Trial. N Engl J Med. 2000;342:1953-1958.
-
(2000)
N Engl J Med
, vol.342
, pp. 1953-1958
-
-
Schulman, S.1
Lindmarker, P.2
-
23
-
-
4644288189
-
Prevention of venous thromboembolism
-
The Seventh ACCP Consensus Conference on Antithrombotic and Thrombolytic Therapy
-
Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism. The Seventh ACCP Consensus Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 suppl):338S-400S.
-
(2004)
Chest
, vol.126
, Issue.3 SUPPL.
-
-
Geerts, W.H.1
Pineo, G.F.2
Heit, J.A.3
-
24
-
-
4644221063
-
Antithrombotic therapy for venous thromboembolic disease
-
The Seventh ACCP Consensus Conference on Antithrombotic and Thrombolytic Therapy
-
Büller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. The Seventh ACCP Consensus Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 suppl):401S-428S.
-
(2004)
Chest
, vol.126
, Issue.3 SUPPL.
-
-
Büller, H.R.1
Agnelli, G.2
Hull, R.D.3
|